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Abstract 
 
Background. Pneumonia is the leading infectious cause of death worldwide. HIV 
infected and exposed children are at greater risk for developing pneumonia. HIV 
exposed infants have been said to have a worse outcome than their HIV unexposed 
counterparts. 
 
Objectives. To describe the patient characteristics and determinants of the outcome 
of children admitted to the paediatric intensive care unit (PICU) with pneumonia. 
 
Methods. This was a retrospective review of patients admitted to a PICU between 1 
January 2013 and 31 December 2014. 
 
Results. One hundred and seven patients were analyzed, of these 65.4% had a 
normal weight for age. Fifty percent of patients were HIV unexposed, 21.5% HIV 
infected and 26.2% HIV exposed but uninfected. The HIV infected group had a 
significantly longer length of stay (p= .011), duration of ventilation (p= .003) and 
higher mortality (p= .014) when compared to the HIV uninfected group. Likewise 
compared to HIV exposed but uninfected children, HIV infected had a longer length 
of stay (p=. 006), duration of ventilation (p= .003) and a greater mortality (p= .038). 
When the oxygenation index is ≥16, patients had a longer duration of ventilation (p= 
.037) and they had an increased risk of mortality (p< .001) Multiple regression 
showed that oxygenation index was the only significant predictor of death. 
 
Conclusion. HIV infected children had a significantly higher mortality than both HIV 
uninfected and HIV exposed but uninfected children. An oxygenation index of greater 
than 16 is a significant predictor for longer duration of mechanical ventilation and 
death. 
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Chapter 1: Introduction 
1.1. Pneumonia: aetiology, incidence and mortality 
 
Pneumonia is an acute respiratory infection that affects children of all ages (1). In the 
developed world, there were approximately four million cases per annum in children 
aged less than five years. This was in stark contrast to the developing world, where 
there were 151.8 million new cases of pneumonia in the same age group annually 
(2). Of these cases, between 8.7 to 12% were severe enough to require 
hospitalization as determined by the treating doctor (2, 3). Pneumonia is the leading 
cause of hospital admission in the United States of America of children outside the 
neonatal period (4). 
 
The World Health Organization (WHO) stated that pneumonia is the leading 
infectious cause of death in children worldwide (1, 3). In children under 5 years of 
age it accounted for 15% of all deaths annually (1, 3, 5, 6). The mortality rate from 
pneumonia, in the developing world, was substantially greater than the developed 
world, a situation that mirrored the significant discrepancy in their respective 
incidence rates (2). The African region had the greatest burden of deaths from 
pneumonia accounting for almost 50% of the worldwide total (Table 1.1) (2, 3). 
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Table 1.1 Burden of pneumonia by WHO region (3) 
 Population 
between 0-4 
years (2010) 
Incidence 
(episodes 
per child 
year) 
Total 
episodes 
(x 106) 
Total 
severe 
episodes 
(x 106) 
Total 
deaths 
(x 103) 
African 
region 
133 340 762 0.27 36.40 4.17 540.60 
American 
region 
76 995 700 0.08 6.40 0.78 23.90 
European 
region 
54 605 243  0.03 1.60 0.41 18.10 
South East 
Asian 
region 
179 956 087 0.26 47.40 5.44 443.80 
World 633 461 337 0.19 120.40 14.11 1256.80 
 
The WHO Clinical Case Definition of pneumonia was streamlined in 2012 to ensure 
ease of treatment. Previously, pneumonia was merely defined as fast breathing and 
was treated routinely with oral amoxicillin. Severe pneumonia included chest wall 
indrawing and was treated with injectable penicillin or ampicillin. Data has shown that 
oral amoxicillin was as efficacious as injectable penicillin or ampicillin for children with 
severe pneumonia and so the need for a distinction between these two groups was 
thus made redundant (7). The new definition of pneumonia included a history of 
cough with tachypnoea and/or chest wall indrawing. Severe pneumonia was defined 
as pneumonia with any general danger sign, which included the child being lethargic, 
not tolerating any feeds or vomiting everything (7). Pneumonia can be treated with 
oral antibiotics whereas severe pneumonia should be referred to a hospital and 
treated with injectable antibiotics (7). The lack of consensus on the definition of 
pneumonia and its severity created problems around researching this topic (5, 8). 
Consequently some authors have used admission to an Intensive Care Unit (ICU) to 
define severe pneumonia for research purposes (9). 
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Risk factors for pneumonia included: children who were less than five years of age, 
low birth weight, sub-optimal breastfeeding, poor nutritional status, overcrowding, 
exposure to indoor air pollution, including passive cigarette smoke and open fires, co- 
morbidities, including asthma and Human Immunodeficiency Virus (HIV), and 
preceding upper respiratory tract infections(4, 10-13). Malnutrition, young age and 
crèche attendance seemed to be the most noteworthy of these factors (12, 13). 
Children who had any anthropometric deviation from the norm were all shown to be 
at increased risk for pneumonia (4, 14). 
 
Pneumonia can be caused by a myriad of aetiological agents from the three most 
common groups of pathological microorganisms. Bacterial and viral pneumonias are 
far more prevalent than fungal pneumonias. In South Africa, the double hit of a high 
prevalence of HIV and protein energy malnutrition in children has created a high 
burden of immunosuppression which has had a significant influence on the 
aetiological agents responsible for pneumonia (2, 15, 16). These children are at 
substantially increased risk of pneumonia from more uncommon agents such as 
Pneumocystis jiroveci and Cytomegalovirus (CMV) (2, 8). 
 
1.2. The effect of the HIV pandemic on children 
 
Globally 36.7 million people were living with HIV in 2015; this included 3.4 million 
children less than 15 years of age (17, 18). It is estimated that 40% of women living 
in Southern Africa are HIV infected (19). Without treatment, 25-30% of babies born to 
HIV infected mothers will acquire HIV infection in-utero, during labour and delivery 
and throughout breastfeeding (17, 20). 
 
All children born to mothers who are HIV positive are termed HIV exposed infants. If 
they have a positive HIV DNA polymerase chain reaction (PCR) test before 18 
months of age or a positive enzyme linked immunosorbent assay (ELISA) or PCR 
after 18 months of age, then they are HIV positive. Children who were exposed but 
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have had a negative PCR test at less than 18 months are then termed HIV exposed 
but uninfected (HIV EU). 
 
Perinatal transmission of HIV has decreased drastically with mothers having better 
access to lifelong combined antiretroviral therapy, improved obstetric management 
and changes in infant feeding practices combined with infant prophylaxis (21-23). 
HIV EU babies now account for as many as 30% of all births in parts of Southern 
Africa (19, 21, 24). HIV EU children are considered a vulnerable population and 
because of this, have been a point of interest in the literature of late (25). HIV EU 
children have had an increased morbidity and mortality rate when compared to their 
HIV unexposed counterparts (26). This was thought to be multifactorial and included 
an increased exposure to infectious pathogens from HIV infected relatives resulting 
in more infections than unexposed children, poorer early growth, impaired immune 
systems, including reduced antibody levels, exposure to antiretroviral drugs in utero 
and reduced duration of breastfeeding (10, 19, 22, 25, 26). These children also 
suffered adverse social and economic factors of being born into an HIV affected 
household, such as ill parents who may not be able to provide financially or 
emotionally for the child (10, 11, 19, 21-23, 26, 27). 
 
1.3. HIV and ICU Outcomes 
 
The HIV pandemic has placed even greater demands on scarce Paediatric Intensive 
Care Unit (PICU) services in developing countries (28, 29). Historically, HIV infected 
children that required admission to a PICU for ventilation for a respiratory tract 
infection had a high mortality rate (28-30). Mortality for HIV infected children, with 
AIDS defining illnesses, was shown to be up to 100% in a study conducted prior to 
the introduction of Antiretroviral Drugs in South Africa (30). The mortality rate 
decreased significantly following the introduction of antiretroviral agents (29, 30). 
Mortality was then further reduced with the addition of corticosteroids to therapeutic 
regimens for Pneumocystis pneumonia (29, 30). Most of the literature shows a higher 
mortality rate in HIV infected patients as compared to HIV uninfected (20, 28, 29, 31). 
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A study done at Steve Biko Hospital in South Africa showed that HIV infected 
children with respiratory failure were also shown to have a higher mortality rate than 
their HIV EU counterparts (20). HIV infected and HIV EU children had a longer 
duration of mechanical ventilation as well as a longer stay in the PICU when 
compared to HIV unexposed children (20, 31). 
 
1.4. Malnutrition - A major burden in the developing world 
 
In children under five, malnutrition is a significant cause of morbidity and mortality in 
developing countries throughout the world (16, 32-34). Furthermore, malnutrition is 
common in the ICU setting on admission, even in developed countries (33, 34). The 
impact of malnutrition on ICU outcomes has been mostly unreported in developing 
countries, however severely malnourished children were found to have both 
increased durations of mechanical ventilation as well as lengthier stays in the ICU 
(33). 
 
Estimation rates of worldwide malnutrition indicated that 35.8% of preschool children 
were underweight in developing countries (weight for age less than -2 standard 
deviations), 42.7% were stunted (height or length for age less than -2 standard 
deviations) and 9% were wasted (weight for height/length less than -2 standard 
deviations) (35). A child was said to be severely underweight, stunted or wasted 
when they had plotted below the -3 standard deviation as for the above mentioned 
definitions (35). A study done at the Chris Hani Baragwanath Academic Hospital 
(CHBAH) to determine the prevalence of malnutrition in the general paediatric wards 
in 2012 showed that 40.5% of children admitted to a general paediatric ward were 
stunted and 33.3% were underweight for age, which is comparable to the worldwide 
estimates. However, there was a large discrepancy in wasting with 23.4% of children 
at CHBAH fell into this group compared to world estimates which showed 9% of 
children were wasted (16). The same study showed HIV EU children were 
significantly more underweight and stunted when compared to their HIV unexposed 
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counterparts. Eighty one percent of unexposed children had normal anthropometry 
while only 25% of the HIV exposed children did (16). 
 
1.5. Paediatric Index of Mortality 
 
The Paediatric Index of Mortality (PIM) 3 score has been successfully used to assess 
mortality risk when enrolling patients into clinical trials in ICU’s (36, 37). Furthermore 
it has also been utilized as a benchmarking tool to monitor the quality of Intensive 
Care delivery. Studies to evaluate the calibration of the score have shown that often 
the risk of mortality was underestimated (36, 37). Eight variables are used in this 
point of care score in the first hour of ICU admission including: 
- systolic blood pressure 
- papillary reaction to bright light  
- base excess in arterial or capillary blood 
- 100 x FiO2/PaO2 (mmHg) 
-  whether the patient required mechanical ventilation within the first hour in ICU 
- whether it was elective admission to ICU 
- whether recovery from surgery is the main reason for admission 
- grading of the diagnosis as low, high or very high risk (36). 
 
The PIM score adjusts for the severity of illness, the diagnosis and underlying chronic 
conditions, however this model was created in a developed world setting and 
therefore may not account for all factors affecting outcomes of children in the 
developing world (38). While the PIM 2 score, which included HIV status, has been 
evaluated in a South African setting the PIM 3 score has not (39). In a South African 
setting with a high burden of HIV, the results of the PIM score may be affected.  
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1.6. The Oxygenation Index and Paediatric Acute Respiratory Distress 
Syndrome 
 
There are different measures of hypoxemia including P/F ratios, oxygenation index 
(OI) and oxygen saturation index (OSI). The P/F ratio is greatly influenced by 
ventilator pressures, which has resulted in OI being used preferentially by some 
paediatric practitioners (40). The PICU tended to have a larger variability in ventilator 
strategies compared to adult ICU’s thus necessitating the need for an indexed 
measure of lung function from an oxygenation point of view (40).The equation for the 
OI is as follows [(Mean airway pressure x Fraction of inspired oxygen)/Partial 
pressure of oxygen x 100] (40, 41). It was recently recommended by the Paediatric 
Acute Lung Injury Consensus Conference (PALICC) that OI should be the primary 
measure of lung disease severity in Paediatric Acute Respiratory Distress Syndrome 
(PARDS) (Table 1.2) (40). As with the Berlin classification, (current acute respiratory 
distress syndrome classification for adults) PARDS can be divided into mild, 
moderate and severe (40). The prognostic value of OI has been previously shown 
(41). Higher peak OI is an independent predictor of mortality in patients with 
hypoxaemic respiratory failure (41). 
 
Table 1.2 The Severity Classification of PARDS 
 
 
 
 
Classification Oxygenation Index 
Mild PARDS 4 ≤ OI < 8 
Moderate PARDS 8 ≤ OI < 16 
Severe PARDS  OI ≥ 16 
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1.7. Demographics and outcomes in PICU 
 
There is a paucity of information related to the paediatric intensive care 
demographics in the developing world (42). Of the studies done, there seemed to be 
a male predominance of the population admitted to PICU (42, 43). The average 
length of stay of non survivors tended to be shorter than those discharged from the 
ICU, it was noted however, that this was because deaths occurred early on in the 
admission (42, 44). Studies in Johannesburg, Bangladesh and Colombo, Sri Lanka 
showed majority of admissions were for respiratory problems (42-44). 
 
There was a vast range of mortality rates reported from both developing and 
developed countries (43-47). A study in Melbourne showed an overall mortality rate 
as low as 6% for PICU admissions, but when they analysed admissions within this 
cohort from a serious infection in the blood or lungs, the mortality increased to 17.5% 
(46). Whilst a study in a PICU in India reported a gross mortality rate of only 6.7%, 
only 20.7% of the patients studied required mechanical ventilation (45). Previous 
studies in a South African setting showed mortality rates as high as 32-35% but 
these studies were both conducted just before the role out of antiretroviral therapy 
(44, 47). 
 
1.8. The Chris Hani Baragwanath Academic Hospital 
 
The Chris Hani Baragwanath Academic Hospital (CHBAH) is a tertiary level hospital 
located in Soweto, Johannesburg. As a tertiary hospital, it accepts patients from 
primary and secondary referral centres as well as providing sub specialist care. With 
respect to paediatrics, there are approximately 450 combined paediatric in-patient 
beds at CHBAH and approximately 5200 paediatric medical admissions per annum. 
Given the relatively scarce economic resources of state hospitals in South Africa, the 
PICU at CHBAH has only 8 dedicated beds which accommodate approximately 350 
admissions per year. Despite the ratio of PICU beds to paediatric beds being far less 
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than internationally recommended norms, the PICU accepts patients not only from 
CHBAH itself, but also from surrounding referral hospitals, in a catchment area which 
stretches as far as the North West Province (48). 
 
 The PICU operates on a “closed” ICU system which means that once the patient is 
admitted to the PICU, the patient is primarily treated by the paediatric intensivist with 
the primary physician assuming a predominantly consultative role with respect to the 
patient’s care(49). 
 
Each candidate is triaged by an intensivist, before they are accepted to the ICU. 
Regularly, the request for ICU beds exceeds the availability of these beds on any 
given day and thus the beds are allocated to the best possible candidates deemed 
most likely to obtain the greatest magnitude of benefit from ICU admission following 
the triage process. 
 
This study intends to describe the population of children admitted to the PICU at 
CHBAH with a primary diagnosis of pneumonia. The prevalence of HIV infection and 
exposure and malnutrition in this population will specifically be sought. The outcomes 
of these patients will be analyzed within the above categories and any differences 
noted will be illustrated. There have been no studies at the CHBAH PICU exploring 
the outcomes of HIV exposed children with pneumonia.Given the high burden of HIV 
and malnutrition among the patients of the CHBAH, this study hopes to provide vital 
epidemiological data that is not currently available. 
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Chapter 2: Methods 
2.1. Aim and Objectives 
Aim 
To establish the patient characteristics and PICU outcomes of children admitted with 
pneumonia. 
Objectives 
a. To describe the following short term PICU outcomes: 
1. Survival to discharge from PICU, or death 
2. Length of stay in PICU 
3. Duration of mechanical ventilation 
b. To determine the number of children admitted to PICU with pneumonia and 
to classify what percentage of these children are HIV infected, HIV 
uninfected and HIV exposed but uninfected.  
c. To classify the nutritional status of the children admitted to PICU with 
pneumonia. 
d. To describe the oxygenation index of patients admitted with pneumonia on 
admission, with relation to: 
1. Duration of mechanical ventilation 
2. Mortality 
e. To determine the Paediatric Index of Mortality 3 score for each child that is 
admitted. The variables collected have been described in the introduction. 
 
2.2. Study design 
 
This study was a retrospective, descriptive study. 
 
 
 
 
 
  11 
 
2.3. Study site 
 
Data collection occurred from medical records from CHBAH PICU. The files were 
retrieved from the CHBAH ICU medical records room. 
 
2.4. Study period 
 
The study took place between 1 January 2013 and the 31 December 2014. 
 
2.5. Study population 
 
The study population included all patients admitted to PICU at CHBAH with the WHO 
clinical diagnosis of pneumonia. There are approximately 5200 admissions to the 
paediatric medical general wards annually. The PICU has 8 dedicated beds which 
accommodate approximately 350 admissions per year, including surgical admissions. 
Patients are accepted into PICU after being triaged by the intensivist covering for that 
day. The triage process is based on the clinical discretion of the intensivist on triage, 
there are no standardized admission criteria. The catchment area for CHBAH not 
only covers the large population of Soweto and the surrounds but stretches into the 
North West province. 
 
There have been no vaccination changes during this study period and so this should 
not affect the study population. 
 
2.5.1. Inclusion criteria 
 
a. Patients admitted to the PICU below the age of 16 years. 
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2.5.2. Exclusion criteria 
 
a. Only patients with a primary diagnosis of pneumonia were included in the 
study. Patients with ventilator associated pneumonia and surgical or 
trauma patients with pneumonia were not included. 
 
2.6. Data Instruments 
 
A data sheet (Appendix A) was generated in order to collect data from the medical 
records. Variables included in the study were demographics, weight on admission 
and WHO classification of weight, duration of admission, duration of invasive 
mechanical ventilation, HIV status, ventilator parameters, blood gas parameters and 
survival to death or discharge from PICU as well as PIM3 variables. 
 
2.7. Data Collection 
 
The data sheets were completed, using patient records, by the researcher. When 
complete records were not available for full data analysis outcome was still recorded 
and analysed accordingly. 
 
2.8. Data Management 
 
Data collected from the data sheets was exported to Microsoft Office Excel 2007. 
Data was checked and cleaned on Excel. 
 
2.9. Data Analysis 
 
Statistical analysis was performed using data analysis software package Statistica 12 
(Statsoft, Inc). Continuous variables were checked using the Shapiro Wilk test and 
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found to be abnormally distributed and are therefore described using median and 
interquartile ranges. The study population was divided into 3 groups when comparing 
HIV status (HIV EU, HIV U and HIV I), 4 groups when comparing weight (Overweight, 
normal weight, underweight and severely underweight) and 2 groups when 
comparing outcome (lived and died). The Mann-Whitney U test was then used for 
comparison of two groups as the data was abnormally distributed. For example 
comparing weights within HIV exposed but uninfected, HIV infected and HIV 
uninfected groups. The categorical variables were described using percentages and 
frequencies. Comparisons of proportions were done using the chi-square test or 
Fisher exact test were appropriate. A p-value of ≤ 0.05 was considered to be 
significant. 
 
A Receiver Operating Characteristic curve (ROC curve) was drawn for OI after the 
sensitivity and specificity of OI had been determined using specific cut offs for OI. 
 
A multivariate logistic regression model was used to determine the independent and 
interactive effects of oxygenation index, gender, age, sex and HIV status as predictor 
variables on the outcome variable, death. Certain variables could not be entered into 
the model due to the collinearity with another variable entered in the model; these 
variables included weight as it correlated with age, length of stay and ventilation 
days; PIM3 and probability scores were all correlated with oxygenation index. 
Outcome, sex and HIV status were assigned dummy variables. HIV status could only 
be recorded as positive or negative as further subdivisions resulted in the groups 
being too small for analysis. 
 
Anthropometry was analyzed using WHO STAT GrowthCharts™. 
 
 
2.10. Finance 
 
The investigator was responsible for all costs of this study. 
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2.11. Ethical Considerations 
 
The proposal for this study was approved by Ethics Committee for Research in 
Human Subjects at the University of the Witwatersrand (Medical). Clearance 
certificate number: M150861 (See Appendix B) Permission to conduct the study was 
also obtained from the medical director of the Paediatric Intensive Care Unit (See 
Appendix C) and the Medical Advisory Committee of the Chris Hani Baragwanath 
Academic Hospital (See Appendix D). 
 
Due to the retrospective nature of the study, the ethical committee waived the need 
for informed consent to be obtained from individual patients. All data was de-
identified so as to maintain patient confidentiality. The data sheets that were 
completed by the researcher were kept locked in a sealed drawer. 
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Chapter 3: Results 
 
3.1. Demographic characteristics of patients 
 
One hundred and seventeen patients were eligible for the study, 10 of files could not 
be found in the records room and therefore the only data available for these 10 
patients was outcome, which has been recorded. The final sample size where files 
were available was 107, consisting of 60 males (56.07%) and 47 females (43.93%). 
The median age was 3.91 months (IQR: 2.70 – 8.88 months), with ages ranging from 
29 days to 9 years 7 months. Age distributions are shown in Figure 3.1, noting that 
78.50% of patients were less than one year of age. 
 
 
Figure 3.1: Age distribution of patients 
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3.2. Weight and Classification by Nutritional status 
 
The median weight was 5.00kg (IQR: 4.40-6.70kg). According to the WHO growth 
charts, only 2 children (1.87%) in the sample were overweight for age, 13 (12.15%) 
were underweight and 22 (20.56%) were severely underweight for age. Almost two 
thirds of the patients had normal weight for age (65.42%). Figure 3.2 illustrates 
weight for age for all patients in the study; percentages are rounded to the nearest 
whole number. 
 
 
Figure 3.2: Weight for age of all patients according to WHO classification  
 
3.3. Classification by HIV status  
 
By the conventional definition of HIV status, 82 patients (76.64%) were HIV negative 
and 23 (21.50%) patients were HIV positive and 2 (1.87%) patients had unknown HIV 
statuses. Among the HIV negative patients, 54 (65.85%) were born to HIV negative 
mothers and 28 (34.15%) were born to HIV infected mothers (HIV exposed). This is 
illustrated in Figure 3.3. 
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Figure 3.3: Known HIV statuses of patients in the study (n=105). 
 
3.4. PIM 3 score 
 
The median PIM 3 score was -2.55 (IQR: -3.05 to -2.14). The PIM 3 score had a 
range from -6.18 to 0.04 which equated to a mortality risk of 0.2% to 51%. 
 
3.5. Oxygenation Index 
 
The median OI was 10.30 (IQR: 6.94-16.30) with a range of 3 to 51.The median OI of 
surviving patients was 8.80 (IQR: 5.96-14.16) and the median OI of the patients that 
died was 23.88 (IQR: 14.89-36.14). The difference was statistically significant (p= 
.005). The distribution of OI comparing patients who survived and patients who died 
is shown in Figure 3.4. 
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Figure 3.4: Box and Whisker plot comparing OI against Outcome 
 
The PALICC definition uses an OI ≥ 16 to define severe PARDS. The mortality rate 
for the group with an OI of < 16 was 6.85% where as in the OI ≥ 16 group it was 
35.29%. 
 
Spearman Rank correlation showed that OI was closely related with both length of 
stay and duration of mechanical ventilation. 
 
3.6. PICU Outcomes 
 
In terms of the primary study objective, of the total 117 patients, 93 (79.49%) were 
discharged from PICU and 24 (20.51%) died. 
 
Box and Whisker Plot of OI comparing Outcome 
Outcome 
Died Lived 
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The length of stay in PICU for all patients (survivors and non survivors) ranged from 1 
to 39 days with a median stay of 8 days (IQR: 5-15 days).The median length of PICU 
stay for patients who were discharged (survivors) was 8 days (IQR: 5-15) and 11 
days (IQR: 7-17) for non-survivors (p= .366). Figure 3.5 compares the length of stay 
in PICU separating patients that were discharged from those who died.  
 
Box Plot of LOS (fixed) grouped by  Outcome
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Figure 3.5: Box and Whisker plot comparing Length of Stay and Outcome 
 
The median length of mechanical ventilation for all patients was 7 days (IQR: 4-14 
days). 
Outcome 
Box and Whisker Plot of LOS comparing Outcome 
Lived Died 
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3.7. Grouping by WHO weight for age classification 
 
Patients were divided into four groups based on their WHO weight for age 
classification. The four groups were overweight, normal, underweight and severely 
underweight. Table 3.1 describes the four group’s characteristics 
 
Table 3.1: Comparison of patients according to WHO weight for age classification  
Characteristic Overweight 
(n=2)          
Normal  
(n=70) 
Underweight 
(n=13) 
Severely UW 
(n=22) 
Sex (male) 0 (0%) 
 
39 (55.71%) 7 (53.85%) 14 (63.63%) 
Age (months) 8.32           
(2.70-13.94) 
3.07           
(2.14-8.58) 
4.70             
(4.24-14.96) 
3.95             
(3.32-5.29) 
Length of 
stay (days) 
15.50            
(13-18) 
8.50                
(6-15) 
6                   
(5-10) 
8.50                
(5-21) 
Ventilator 
days 
14               
(10-18) 
7                   
(4-13) 
5                   
(4-9) 
7                   
(4-20) 
Oxygenation 
Index 
7.74             
(5.95-9.54) 
9.99             
(5.75-16.06) 
15.60           
(8.36-31.48) 
11.03           
(8.18-16.13) 
Outcome 
(survived) 
2 (100%) 59 (84.28%) 10 (76.92%) 19 (86.36%) 
PIM 3 score -5.21 
 
-2.69 -2.24 -2.49 
Probability of 
death 
0.60% 4% 9% 8% 
Continuous variables are reported in medians and interquartile ranges. 
 
There was a male predominance in all groups except the overweight group, in which 
both of the patients were female. There was a significant difference between the 
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children with normal weight for age and the underweight children in regards to age 
(p= .028) but no other significant differences were found between the groups. 
 
3.8. Grouping by HIV status 
 
Table 3.2: Comparison of HIV I, HIV EU and HIV U for demographics and outcomes, 
including p values comparing HIV I to the other groups  
Characteristic HIV U(n=54) HIV EU 
(n=28) 
HIV I (n=23) p 
value† 
p 
value* 
Sex (male) 33 (61.11%) 14 (50%) 13 (56.52%) .707 .642 
Age (months) 4.06 (2.60-
9.04) 
4.27 (2.48-
7.02) 
3.72 (2.73-
5.88) 
.864 .993 
Weight (kg) 5.20 (4.50-
8.00) 
5.20 (4.25-
6.20) 
4.74 (4.40-
5.50) 
.181 .714 
Length of stay 
(days) 
8 (5-13) 6.50 (4-
12.50) 
15 (8-21) .011 .006 
Ventilator days 7 (4-11) 5 (3-10.50) 14 (7-21) .003 .003 
Oxygenation Index 9.37                 
(5.94-15.95) 
8.90          
(6.27-
13.41) 
15.82       
(11.28-
23.88) 
.008 .003 
Outcome 
(survived) 
88.89% 89.29% 65.22% .001 .038 
PIM 3 Score 
(median) 
-2.75 -2.58 -2.38 .106 .057 
Probability of 
death 
6% 7% 9% .088 .029 
Note: HIV U = HIV Uninfected, HIV EU = HIV Exposed but Uninfected, HIV I = HIV 
Infected and †p-value comparing HIV-I and HIV-U, *p-value comparing HIV-I and 
HIV-EU. Continuous variables are reported in medians and interquartile ranges  
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3.8.1. HIV U vs HIV EU 
 
Despite the difference in HIV exposure the two groups had no significant differences 
in either their baseline characteristics or PICU outcomes. 
 
3.8.2. HIV I vs HIV Negative (HIV U and HIV EU) 
 
The HIV I group was compared to the HIV U and HIV EU groups respectively with 
regards to their baseline characteristics and PICU outcomes. There were no 
significant differences found with respect to sex (p=.707, p=.642) age (p=.864, 
p=.993) or weight (p=.181, p=.714). The HIV I group differed significantly from both 
the other groups in terms of length of stay, length of mechanical ventilation, 
oxygenation indices and survival  (p= .011, p= .003, p= .008, p= .001) (Table 3.2). 
 
Outcome was defined as survival to discharge from PICU or death in the PICU.HIV U 
and HIV EU children had a statistically better chance of surviving to discharge when 
compared to HIV I children (p= .001, p= .038). 
 
 There was a significant difference in the probability scores when comparing the HIV 
EU group to the HIV I group (p= .029). The PIM 3 score of the HIV I group was not 
statistically different to the other groups (p=.106, p=.057).
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3.9. Analysis based on the Oxygenation Index (OI) 
 
The patients Oxygenation indices (OI) were grouped dichotomously into those with 
an OI less than 16 and an OI greater than and equal to 16 as per PALICC definition 
of non-severe and severe PARDS. The baseline characteristics and outcomes of the 
two groups were then compared (Table 3.3). 
 
In relation to the OI, no significant differences were noted in terms of age (p= .201) or 
weight (p=.290). However there was a significant difference among the two groups 
with respect to sex with males being more likely to have higher OI’s (p=.039).  
 
The duration of mechanical ventilation was longer in patients with an OI ≥16 (p=.037). 
Survival was significantly lower in the higher OI group (p<0.001) with a corresponding 
significant difference in PIM3 scores (p<0.001). The mortality rate for the group with 
an OI of < 16 was 6.85% whereas in the OI≥ 16 group it was 35.29% (p< .001). Table 
3.4 outlines the sensitivity and false positive values that were used to generate the 
ROC curve.  
 
Table 3.3: Comparison of groups by Oxygenation Index (OI) 
Characteristic OI < 16  (n= 73) OI ≥ 16  (n= 34) p value 
Sex(male) 36 (49.32%) 24 (70.59%) .039 
Age (months) 3.71 4.52 .201 
Weight (kg) 5 5.25 .290 
Length of stay (days) 8 10 .181 
Ventilator days 7 9 .037 
Outcome (survived) 93.15% 64.71% <.001 
PIM 3 Score -2.85 -2.20 <.001 
Probability 6% 10% <.001 
Continuous variables are reported as median
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Figure 3.6 ROC curve for OI 
Table 3.4: Cut Off Values for ROC curve 
Cut Off Valve OI Sensitivity (Survival) False Positive rate 
50 6 0 
40 12 0 
30 41 3 
25 47 8 
20 53 13 
18 53 14 
16 65 20 
14 76 25 
12 88 32 
10 100 42 
8 100 64 
6 100 82 
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A ROC curve was generated in order to establish the best discriminatory OI in 
relation to mortality for the population of children admitted to our PICU and compare 
it to the PALICC cutoff value of 16. The best possible prediction would occur at a 
point of (0, 1) on a ROC curve as this provides both 100% sensitivity and specificity. 
On this curve, the point chosen to be closest to (0, 1) was a sensitivity of 53% and a 
false positive rate (1-specificity) of 13% which corresponds to an OI of 20-24.9. 
Children with an OI of greater than 20 were more likely to have a poor outcome. 
 
3.10. Independent Predictors of Death 
 
The aim of the multiple regression model was to determine the independent and 
interactive effects of oxygenation index, sex, age, sex and HIV status as predictor 
variables on the outcome variable, death. The following variables were not entered 
into the model due to the collinearity with another variable entered: weight correlated 
with age; length of stay, ventilation days; PIM3 and Probability scores were all 
correlated with oxygenation index.  
 
Death (lived or died); sex (male or female) and HIV status (HIV positive or HIV 
negative) were assigned dummy variables for the regression model. Further 
separation of the HIV group into HIV negative, unexposed; HIV negative, exposed; 
and HIV positive was not possible to the small numbers in the subgroups. OI, gender, 
age, sex and HIV status were entered into the multiple regression model as 
independent variables. Outcome was entered as the dependent variable.  
 
Results from the multiple regression model showed that overall the model was 
statistically significant (F (5, 99) = 9.90, p< .001, R2 = .33, R2Adjusted = .30). The 
analysis showed that OI was the only significant predictor of death in a South African 
paediatric population (p< .001). Sex (p = .70), age (p = .14), and HIV status (p = .13) 
were unrelated to death.  
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Chapter 4: Discussion 
 
The aim of this study was to describe the PICU population at CHBAH with a primary 
diagnosis of pneumonia and report the short term outcomes of these children. 
Additionally, this study also aimed at grouping the population by HIV status, 
nutritional status and oxygenation index to describe the clinical features and 
outcomes associated with each group.  
 
Data analysis showed that overall; there was a slight male predominance in this 
sample, which seems to be in keeping with the literature (42, 43). Only 22% of the 
sample was more than a year of age and the majority of the sample had a normal 
weight for age. Importantly, the HIV status was reported for the majority of the 
sample (98%). With regards to HIV status, the majority of patients were HIV 
uninfected (77%) of which 34% (26% overall) were exposed to HIV. Twenty one 
percent of the sample was HIV infected.  
 
In terms of the primary objectives of the study, 79% of the patients were discharged 
from the PICU. This overall mortality rate has improved from previous South African 
studies which had rates of 32-35%, although it is still significantly higher than that 
found in a developed setting which ranged from 6% as an overall mortality rate and 
up to 17.5% in children with serious bacterial infections and pneumonia (44, 46, 47) 
The median ICU length of stay was 8 days which is in keeping with other PICU’s in 
tertiary institutions in the developing world, ranging from 5-8 days (42).  
 
4.1. Grouping by Weight 
 
When placing the underweight and severely underweight group together, 32.7% of 
the sample was underweight which is comparable to in-patient estimates found in 
2012 at the CHBAH where 33.3% of children were underweight for age. (16) 
Somewhat surprisingly, this study showed that there was no difference in outcome, 
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PIM 3 or probability scores when comparing all weight for age groups. While severe 
malnutrition is an important risk factor for mortality, there is a paucity of data 
confirming the link between malnutrition and mortality in an ICU setting (33, 34). In 
this study, ex premature infants were not plotted by their corrected age and weight 
for age was used to determine nutritional status, not weight for height, this may 
account for the results shown. 
 
4.2. Grouping by HIV status 
  
The prevalence of HIV infection among the patients in this study was 22%. This is 
nearly twice that of the prevalence previously reported among paediatric inpatients at 
the Chris Hani Baragwanath Academic Hospital in 2012 (13). This seems somewhat 
counterintuitive given the apparently successful roll out of antiretroviral therapy in 
South Africa during this time period. However, it is difficult to draw direct comparisons 
between an ICU population and the general wards as the patients admitted to the 
ICU are likely to be the sickest of all patients and due to this selection bias may have 
prevalence’s of certain characteristics such as HIV infection in excess of the general 
inpatient population. Furthermore, this study specifically looked at patients with a 
primary diagnosis of pneumonia, which furthers increases the likelihood of underlying 
immunosuppression as opposed to the patients admitted to PICU with a primary 
diagnosis of trauma, for instance. Thus this study has established the prevalence of 
HIV infection among this particular population and furthermore serves to illustrate 
that HIV infection is not a contra-indication to the provision of intensive care.  
 
The HIV I group had both significantly longer ICU length of stay and duration of 
mechanical ventilation when compared to either the HIV EU or HIV U groups, which 
is in keeping with the literature (22, 31). Studies have shown that HIV EU children 
have behaved similarly to HIV I children (22).However, in this study HIV EU children 
behaved similarly to the HIV U children. There was no statistical difference noted 
when comparing length of stay in HIV EU and HIV U children. 
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The oxygenation index was also significantly higher in the HIV I group when 
compared with the HIV EU and HIV U groups. OI was closely correlated with both 
length of stay and duration of mechanical ventilation so it is not surprising that the 
groups have similar findings in OI and duration of stay and ventilation. 
 
In previous studies, HIV EU children have been found to have poor early growth 
when compared to HIV U peers (19, 23). In this study where the majority of the 
participants were under one year of age, the HIV EU and HIV U groups had the same 
median weight while the HIV I groups’ weight, although slightly less, was not 
significantly different statistically. A study conducted in the general paediatric wards 
at CHBAH showed that HIV I children were more underweight than the HIV U 
children, which is in keeping with these results (16). 
 
HIV EU children have been described as a vulnerable group of children, thus far the 
mortality rate among these children had been comparable to rates among HIV I 
children (11, 21-23, 26, 27). However, in this study the outcomes of the HIV EU 
appear more closely related to the HIV U group and in fact were significantly more 
favourable than their HIV I counterparts.  
 
HIV EU children receive the same treatment as their HIV I counterparts as they have 
been shown to be at increased risk for severe pneumonia with organisms that would 
not usually infect immune competent children (20). Given the results from this study, 
further investigation is definitely warranted to decide if these children should still 
receive the same treatment as HIV I children, in particular empiric treatment of both 
Pneumocystis jiroveci and CMV pneumonia. 
 
4.3. PIM and Probability 
 
There are no studies that have been conducted in South Africa validating the PIM 
score. In this study the PIM score was also only used for a population that had 
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pneumonia, perhaps when used on the entire PICU population, the predicted and 
actual mortality rate may correlate better. In this study, the median probability of 
death was under predicted in each category that it was analyzed. 
 
Previously in the PIM 2 score HIV status was considered a high risk diagnosis but 
when PIM 3 was being tested, HIV infection was not shown to be an increased risk 
for death and was therefore removed from the revised model (38). In this sample the 
probability of death, using the PIM 3 score, for HIV I group was 8.5% and the actual 
mortality rate was 34.8% in this group. In the developed world where all children who 
are HIV I have immediate access to testing and receiving early antiretroviral therapy 
before they even become symptomatic, HIV status may not affect the predictive 
score with PIM 3. Conversely, in the developing world where some children are only 
diagnosed HIV I when they present with severe pneumonia, including HIV status as a 
high risk diagnosis may improve the accuracy of the predicted mortality. 
 
4.4. Oxygenation Index 
 
There is very little published work on oxygenation index and outcome in a South 
African setting. For simplicity, the OI was grouped dichotomously as less than 16 or 
greater than and equal to 16. An OI of greater than and equal to 16 is the cutoff for 
severe PARDS (40). The evidence in this study shows that with an OI of greater than 
16, the length of mechanical ventilation was longer, the PIM 3 predicted probability of 
mortality was significantly worse and the survival rate was less for this group. 
 
When looking at the ROC curve, the OI that was found to be most discriminatory was 
between 20-24.99. This could be helpful when trying to ration ICU resources as this 
information can be used by intensive care practitioners to make more informed 
decisions when faced with severely ill children. The OI can be used in conjunction 
with other parameters to support decisions to either continue or withdraw life 
sustaining therapies depending on the predictable outcomes of the children. The 
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discriminatory OI from this study is greater than that the OI of 16 used to classify 
severe PARDS by the PALICC group. This difference may reflect the characteristics 
of the population of patients attended to at the CHBAH and therefore provides an 
alternative, locally valid discriminatory reference point for OI. The PALICC group 
utilized values from within the first 24 hours of admission to calculate their OI’s, while 
this study used the first arterial blood gas following admission to calculate OI. The 
significance of this difference is difficult to ascertain (40). 
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Chapter 5: Strengths and Limitations 
 
One of the strengths of this study is that data was collected over a period of two 
years allowing for a good sample size of patients.  
 
The retrospective nature of this study is one of the limitations. Fortunately most of the 
records had been well kept and so only two of the HIV results could not be obtained. 
Also, ten of the patient’s files were missing and therefore this information could not 
be collected in its entirety. Survival to discharge or death were documented for these 
patients and analysed accordingly. Similarly, data on whether or not the patient was 
receiving antiretrovirals was not recorded.  
 
Weight is the only anthropometrical data recorded in the files so no comment could 
be made with regards to stunting or wasting of the children in this study. 
Height/length was not captured in the files and therefore could not be recorded.  
 
 Furthermore, no data was collected as to whether or not the children were born 
prematurely. All weights were plotted according to chronological age and no 
corrected ages were determined. This may have resulted in younger children being 
classified as underweight for age or severely underweight for age when in fact they 
may well have had normal weights for their respective corrected ages. This potential 
over reporting of the number of malnourished children may possibly explain the 
failure of this study to identify any outcome differences between normal and 
malnourished patients as seen in previous studies (33). 
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Chapter 6: Conclusion 
 
The most pertinent finding in this study is that despite advancement in treatment for 
HIV I children over the years, they still have an increased mortality in relation to HIV 
negative children (both HIV exposed and unexposed). They also had a significantly 
longer stay in PICU and longer duration of mechanical ventilation. 
 
This study also showed that in fact, HIV EU children do well in PICU and behaved in 
a similar manner to HIV U children with regards to length of stay, duration of 
ventilation and outcome. 
 
An oxygenation index of more than 16 resulted in a longer duration of mechanical 
ventilation and a significantly higher mortality rate. Furthermore, the ROC curve that 
was generated established a population specific cutoff for OI showing a higher 
mortality when the OI is greater than 20-24.9. 
 
In all groups that were analysed, PIM 3 scores and probability scores derived from 
them under predicted death in this population. 
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Chapter 7: Recommendations 
 
This study shows that HIV I children have significantly poorer outcomes than both 
their HIV U and HIV EU counterparts, making it difficult in a setting of scarce 
resources to justify allocating a bed to an HIV I child over an HIV U or HIV EU child. 
 
Despite the possible contribution made by this study, there are many questions that 
still need to be addressed regarding PICU outcomes of children with pneumonia. 
Possible future research could include: 
 Prospective studies to determine if HIV EU children are truly behaving better 
or similarly to HIV U children 
 Classification of HIV I children by their WHO staging, CD4 count and viral load 
and then determining if there a difference in their outcome 
 Do children who are HIV I and already on combined antiretroviral therapy have 
a better outcome than children who are diagnosed with HIV infection in the 
PICU or shortly before their admission to the PICU? 
 Determining if there is any difference in outcome according to WHO weight for 
age classification if babies that were born prematurely are plotted according to 
their corrected ages 
 All anthropometric data should be collected to determine if HIV EU and HIV I 
children in the ICU are more wasted or stunted than their HIV U peers. 
 PIM 3 scores need to be validated in a South African setting. 
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Appendices 
Appendix A Data Collection Sheet 
DATA COLLECTION TOOL 
Patient Characteristics 
Study Number:  
Age:  
Sex: M/F 
Weight on admission:  
WHO Classification for weight for 
age: 
Overweight/Normal/Underweight/Mod 
underweight/Severely underweight 
Date of admission to ICU:  
Date of discharge from ICU:  
Duration of stay in ICU (days):  
Number of days ventilated:  
Child’s HIV status: Positive/Exposed but Negative/Unexposed 
If HIV positive when was diagnosis 
made: 
Before ICU admission/During ICU admission 
ICU outcome: Discharged/Demised 
 
Ventilator and Blood gas parameters 
 Day 1 (Admission) 
PaO2  
FiO2  
Peak Inspiratory Pressure  
ΔP  
Mean Airway Pressure  
PEEP  
OI  
 
PIM 3 Variables 
  40 
 
Pupils fixed to light: Yes/No 
Elective admission: Yes/No 
Mechanical ventilation in the first 
hour: 
Yes/No 
Absolute value of the base excess 
(mmol/l): 
 
SBP at admission (mmHg):  
SBP²/1000  
OI  
Recovery post procedure? 
Yes, recovery from bypass cardiac 
procedure 
Yes, recovery from non bypass 
cardiac procedure 
Yes, recovery from non cardiac 
procedure 
 
Very high risk diagnosis: Yes/No 
High risk diagnosis: Yes/No 
Low risk diagnosis: Yes/No 
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Appendix B Ethics Clearance Certificate 
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Appendix C  Letter of permission from the Medical director of the Paediatric Intensive 
Care Unit 
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